Clinical Trials on Olfactory Impairment in Switzerland

Total 56 results

University of Bern
University of Zurich; Swiss National Science Foundation; University of Lausanne; University of Geneva, Switzerland and other collaborators

Completed

The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function (ESTxENDS)

Smoking Cessation | Olfactory Disorder

Switzerland
University of Zurich

Recruiting

Longitudinal Investigation of Brain Blood Flow Changes in Neurosurgical Patients

Brain Blood Flow Impairment

Switzerland
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Evaluate the Pharmacokinetics of ACT-541468 in Subjects With Mild, Moderate, and Severe Hepatic Impairment

Hepatic Impairment

Switzerland
University Hospital Inselspital, Berne
Cochlear; Stiftung Besser Hören

Terminated

Telephone vs. Voice Over IP Speech Comprehension in Hearing Aided Subjects.

Hearing-Impairment

Switzerland
University Hospital, Basel, Switzerland
ETH Zurich

Completed

Glucocorticoid Long-term Administration: Effect on Cold Induced Energy Expenditure and Resting Metabolic Rate (GLACIER)

Thermoregulation Impairment

Switzerland
University of Bern

Completed

Long-term Tablet-computer Based Casual Puzzle Video Game Intervention in Healthy Older and Cognitively Impaired Persons

Healthy | Cognitive Impairment | Mild Cognitive Impairment | Acquired Brain Injury

Switzerland
Prof. Christoph M. Michel

Recruiting

Improvement of Memory in Mild Cognitive Impairment

Mild Cognitive Impairment

Switzerland
Ospedale Regionale di Lugano

Recruiting

TMS Treatment of Social Cognition Skills in Mild Cognitive Impairment

Mild Cognitive Impairment

Switzerland
University Hospital Inselspital, Berne
University of Bern

Completed

Virtual Reality Stimulation to Enhance Cognitive Function of Intensive Care Unit Patients

Quality of Life | Cognitive Impairment, Mild

Switzerland
School of Health Sciences Geneva
University Hospital, Geneva; University of Lausanne Hospitals; University of...

Completed

Countervail Cognitive and Cerebral Decline in Mild Cognitive Impairment Patients Using Non-medical Interventions (COPE)

Mild Cognitive Impairment

Switzerland
University Hospital, Basel, Switzerland

Completed

Effect of Ginkgo Biloba Special Extract LI 1370 on Dual-tasking in Patients With MCI

Mild Cognitive Impairment

Switzerland
University of Lausanne

Completed

Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians

Mood Disorders | Urinary Incontinence | Cognitive Impairment | Malnutrition | Osteoporosis | Visual Impairment | Hearing Impairment

Switzerland
University of Bern

Completed

The Effect of tES on a Cognitive Training

Memory Impairment

Switzerland
University Hospital Inselspital, Berne
University of Bern

Suspended

Virtual Reality to Reduce Delirium

Delirium | Cognitive Impairment

Switzerland
University of Bern
Swiss Accident Insurance Fund SUVA

Completed

SelFIT: Internet-based Treatment for Adjustment Problems After an Accident (SelFIT)

Mental Disorder | Adjustment Disorders | Adjustment Impairment | Accident

Switzerland
University of Bern
University of Zurich

Completed

Real-time fMRI Neurofeedback in Patients With MCI

Mild Cognitive Impairment

Switzerland
Zurich University of Applied Sciences

Completed

Validation of the German Version of the Amsterdam Instrumental Activities of Daily Living Questionnaire®

Mild Cognitive Impairment | Mild Dementia

Switzerland
Istituto Nazionale di Ricovero e Cura per Anziani
European Union

Recruiting

engAGE: Managing cognitivE decliNe throuGh Theatre Therapy, Artificial Intelligence and Social Robots drivEn Interventions (engAGE)

Mild Cognitive Impairment | Older Adults

Italy, Norway, Switzerland
University of Zurich
Waid City Hospital, Zurich

Completed

Move for Your Mind - Pilot Trial (MFYM - P)

Mild Cognitive Impairment | Mild Dementia | Fall Prevention

Switzerland
University of Zurich
University of Luebeck

Recruiting

Exploiting the Potential of Neural Attentional Control to Overcome Hearing Impairment (NeurAttContr)

Hearing Loss | Tinnitus | Attention Impaired

Switzerland
University of Zurich

Recruiting

Assessment of Renal Function by Multiparametric MRI

Renal Impairment

Switzerland
Empa, Swiss Federal Laboratories for Materials...
ETH Zurich; Geriatrische Klinik St. Gallen

Unknown

Non-invasive, Wearable Multi-parameter System for the Early Prediction of Cognitive Decline and Dementia in Older Adults

Healthy Aging | Mild Cognitive Impairment

Switzerland
University of Bern

Completed

tES Effects on Associative Memory Performance

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Terminated

Supporting Episodic Memory With Transcranial Direct Current Stimulation in Healthy Controls and Dementia Patients

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Completed

Does Acoustic Stimulation During Sleep Boost Slow Wave Sleep and Memory Performance?

Healthy | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Bern

Recruiting

Tablet-based Cognitive Training

Dementia | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University of Zurich
Avid Radiopharmaceuticals; Swiss Federal Institute of Technology

Active, not recruiting

Imaging Tau Deposition in the Brain of Elderly Subjects (Add-Tau)

Healthy | Neurocognitive Disorders | Alzheimer Disease | Mild Cognitive Impairment

Switzerland
University Hospital, Basel, Switzerland

Recruiting

Validation of a Novel Self-Administered Cognitive Assessment Tool (CogCheck) in Patients With Mild and Major Neurocognitive Disorder Predominantly Due to Alzheimer's Disease (CogCheck-MC)

Neurocognitive Disorders | Cognition Disorders | Mild Cognitive Impairment | Dementia Alzheimers

Switzerland
Andreas Monsch

Completed

Validation of the Montreal Cognitive Assessment in Patients With Mild and Major Neurocognitive Disorder (MoCA-Valid)

Alzheimer Disease | Mild Cognitive Impairment

Switzerland
Eling DeBruin

Unknown

Feasibility Study of an Individualized Exergame Training for Older Adults With MI and/or UI (VITAAL)

Urinary Incontinence | Older Adults | Mobility Impairment

Switzerland
University of Zurich
ETH Zurich

Terminated

Investigating the Clinical Consequences of Flutemetamol-PET-scanning

Dementia | Mild Cognitive Impairment | Alzheimer's Disease

Switzerland
Nicolai Goettel

Recruiting

Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool (CogCheck-Valid)

Cognitive Impairment | Cognition Disorders | Postoperative Delirium | Postoperative Cognitive Dysfunction | Cardiac Surgery | Cognitive Decline

Switzerland
University Hospital, Basel, Switzerland
Stiftung für Krebskranke Kinder

Completed

Study to Evaluate Blood and Urine Kidney Injury Markers to Facilitate Early Detection of Renal Adverse Drug Events in Pediatric Cancer Patients Treated With Nephrotoxic Chemotherapy (Kid-MaCareOnco)

Kidney Impairment

Switzerland
Prof. Christoph M. Michel

Recruiting

Understanding Brain Mechanisms Involved in Autobiographical Memory

Alzheimer Disease | Mild Cognitive Impairment | Memory Loss

Switzerland
University Hospital, Basel, Switzerland
AbbVie; Parkinson Schweiz; Bangerter-Rhyner Foundation

Completed

Training of Psychosocial Skills Based on Cognitive Behavioural Therapy for Patients With Parkinson's Disease (CBT)

Parkinson's Disease | Mild Cognitive Impairment

Switzerland
University of Zurich

Recruiting

Auditory Slow Wave Enhancement in Parkinson Disease and Mild Cognitive Impairment (PDMCI-TS)

Parkinson Disease | Mild Cognitive Impairment

Switzerland
Cantonal Hospital of St. Gallen
Bayer

Unknown

Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis

Multiple Sclerosis | Cognitive Impairment

Switzerland
Cantonal Hospital of St. Gallen
Biogen

Unknown

Neurocognitive Changes in Patients With Remitting Relapsing Multiple Sclerosis Treated With Natalizumab

Multiple Sclerosis | Cognitive Impairment

Switzerland
Swiss Paraplegic Centre Nottwil

Completed

Effects of Antimuscarinics on Cognition in Spinal Cord Injury

Mild Cognitive Impairment | Spinal Cord Injuries

Switzerland
Ecole Polytechnique Fédérale de Lausanne

Recruiting

Re-Orchestration of Interregional Oscillatory Activity to Promote Visual Recovery (R4V)

Stroke | Parkinson Disease | Visual Impairment

Switzerland
Prof. Dominique de Quervain, MD
University Hospital, Basel, Switzerland; Clinical Trial Unit, University Hospital...

Active, not recruiting

Influence of Fampridine on Working Memory in Individuals With Post COVID-19 Condition With Subjective Cognitive Impairment (FamC)

Working Memory | Post-covid-19

Switzerland
Mclean Hospital
Yale University; University of Lausanne

Not yet recruiting

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Cognitive Impairment | Schizophrenia and Related Disorders | Mitochondrial Alteration

United States, Switzerland
Frank Behrendt
Innosuisse - Swiss Innovation Agency

Recruiting

ExerG: Video Game-based Physical Cognitive Training for Patients: a Usability Study (ExerGetic)

Cognitive Impairment | Gait Disorders, Neurologic | Gait Disorder, Sensorimotor | Balance; Distorted | Gait Disorders in Old Age | Functional Movement Disorder | Visual Disorder

Switzerland
Christian Baumann
ETH Zurich

Recruiting

Assessing the Symptomatic Benefit of Acoustic Slow Wave Enhancement in Parkinson Disease

Parkinson Disease | Mild Cognitive Impairment | Huntington Disease

Switzerland
Swiss SOS Study Group
Universitätsklinik für Neurochirurgie, Inselspital Bern; Département des Neurosciences... and other collaborators

Terminated

Swiss SOS MoCA - DCI Study

Stroke | Cognitive Impairment | Subarachnoid Hemorrhage | Delayed Cerebral Ischemia | Complication | Cognitive Deficit | Cognitive Deterioration | Cognitive Deficits Following Cerebral Infarction

Switzerland
Novartis

Completed

A 12 Month Core Study to Assess the Efficacy and Safety of Ranibizumab (Intravitreal Injections) in Patients With Visual Impairment Due to Diabetic Macular Edema and a 24 Month Open-label Extension Study (RESTORE)

Diabetic Macular Edema

Greece, Belgium, Spain, France, Netherlands, Australia, Canada, Germany, Hungary, Italy, Switzerland, Turkey, United Kingdom
Takeda
Zinfandel Pharmaceuticals Inc.

Terminated

Biomarker Qualification for Risk of Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease (AD) and Safety and Efficacy Evaluation of Pioglitazone in Delaying Its Onset (TOMMORROW)

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Germany, Switzerland, United Kingdom, Australia
Bayer

Recruiting

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Visual Impairment | Neovascular Age-related Macular Degeneration (nAMD) | Diabetic Macula Edema (DME)

Germany, Canada, Denmark, France, Italy, Saudi Arabia, Switzerland, Australia, Finland, Netherlands, Sweden, Norway, United Arab Emirates, Japan, United Kingdom
Takeda

Terminated

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

Mild Cognitive Impairment Due to Alzheimer's Disease

United States, Australia, United Kingdom, Switzerland
Biogen

Recruiting

A Study to Learn About the Safety of BIIB080 and Whether it Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age (CELIA)

Mild Cognitive Impairment Due to Alzheimer's Disease | Alzheimer's Disease Dementia

Belgium, United States, Australia, Italy, Spain, Denmark, United Kingdom, Czechia, France, Poland, Switzerland, Germany, Canada, Japan, Finland, Netherlands, Sweden

Clinical Trials on Olfactory Impairment in Switzerland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Norway

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations